日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A clinical-molecular nomogram for predicting early recurrence following resection of initially unresectable colorectal liver metastases

用于预测最初无法切除的结直肠肝转移瘤切除术后早期复发的临床分子列线图

Lu, Yu-Ting; Huang, Xiao-Xia; Chen, Wen-Chuan; Xiao, Qi-Yun; Duan, Jian-Li; Li, Zi-Jing; Pat Fong, William; Wang, Feng-Hua; Li, Yu-Hong; Wang, De-Shen

Erratum: Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation: Erratum

勘误:药理学抗坏血酸通过氧化还原调节抑制 GLUT1 过表达的胃癌细胞生长并增强奥沙利铂的疗效:勘误

Lu, Yun-Xin; Wu, Qi-Nian; Chen, Dong-Liang; Chen, Le-Zong; Wang, Zi-Xian; Ren, Chao; Mo, Hai-Yu; Chen, Ya; Sheng, Hui; Wang, Ying-Nan; Wang, Yun; Lu, Jia-Huan; Wang, De-Shen; Zeng, Zhao-Lei; Wang, Feng; Wang, Feng-Hua; Li, Yu-Hong; Ju, Huai-Qiang; Xu, Rui-Hua

Erratum: Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression: Erratum

勘误:长链非编码RNA UICLM通过作为microRNA-215的ceRNA调控ZEB2表达,促进结直肠癌肝转移:勘误

Chen, Dong-Liang; Lu, Yun-Xin; Zhang, Jia-Xing; Wei, Xiao-Li; Wang, Feng; Zeng, Zhao-Lei; Pan, Zhi-Zhong; Yuan, Yun-Fei; Wang, Feng-Hua; Pelicano, Helene; Chiao, Paul J; Huang, Peng; Xie, Dan; Li, Yu-Hong; Ju, Huai-Qiang; Xu, Rui-Hua

Degradation of IRF6 by TRIM59 in tumor cells triggers PGM1-mediated glycolysis to regulate cell proliferation in neuroblastoma.

肿瘤细胞中 TRIM59 对 IRF6 的降解会触发 PGM1 介导的糖酵解,从而调节神经母细胞瘤的细胞增殖

Zeng Liang, Xu Hui, Li Meng, Qin Liang-Jun, Chen Kai, Wang Feng-Hua, Li Xiaomin, Yang Tianyou, Miao Lei, Wang Hai-Yun

The HNRNPC/CELF2 signaling pathway drives glycolytic reprogramming and mitochondrial dysfunction in drug-resistant acute myeloid leukemia.

HNRNPC/CELF2 信号通路驱动耐药性急性髓系白血病中的糖酵解重编程和线粒体功能障碍

Ma Xiang, Li Haodong, Zhao Ziqi, Li Changchun, Wang Man, Zhang Lele, Zhao Yutong, Su Haipeng, Wang Feng, Hua Jiai

Application and evaluation of NCCN guidelines in health education for lung nodule screening: A perspective

NCCN指南在肺结节筛查健康教育中的应用与评价:一个视角

Wang, Chen-Chen; Zhou, Jian; Zhao, Xue; Gao, Xue; Wang, Feng-Hua; Bu, Ping; Li, Yu-Feng

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023

中国临床肿瘤学会(CSCO):胃癌诊疗临床指南(2023年版)

Wang, Feng-Hua; Zhang, Xiao-Tian; Tang, Lei; Wu, Qi; Cai, Mu-Yan; Li, Yuan-Fang; Qu, Xiu-Juan; Qiu, Hong; Zhang, Yu-Jing; Ying, Jie-Er; Zhang, Jun; Sun, Ling-Yu; Lin, Rong-Bo; Wang, Chang; Liu, Hao; Qiu, Miao-Zhen; Guan, Wen-Long; Rao, Sheng-Xiang; Ji, Jia-Fu; Xin, Yan; Sheng, Wei-Qi; Xu, Hui-Mian; Zhou, Zhi-Wei; Zhou, Ai-Ping; Jin, Jing; Yuan, Xiang-Lin; Bi, Feng; Liu, Tian-Shu; Liang, Han; Zhang, Yan-Qiao; Li, Guo-Xin; Liang, Jun; Liu, Bao-Rui; Shen, Lin; Li, Jin; Xu, Rui-Hua

Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial

在RAS/BRAF野生型且初始不可切除的结直肠癌肝转移患者中,西妥昔单抗联合FOLFOXIRI方案与西妥昔单抗联合FOLFOX方案作为转换治疗方案的比较(TRICE试验):一项随机对照试验

Wang, De-Shen; Ren, Chao; Li, Shan-Shan; Fong, William Pat; Wu, Xiao-Jun; Xiao, Jian; Li, Bin-Kui; Zheng, Yun; Ding, Pei-Rong; Chen, Gong; Qiu, Miao-Zhen; Wang, Zhi-Qiang; Wang, Feng-Hua; Luo, Hui-Yan; Wang, Feng; Wang, Xiao-Zhong; Wang, Ling-Yun; Xie, De-Jin; Chen, Tao; Li, Li-Ren; Lu, Zhen-Hai; Zhai, Xiao-Hui; Liu, Tian-Shu; Yuan, Ying; Chen, Jia-Qi; Tan, Qiong; Pan, Zhi-Zhong; Wan, De-Sen; Zhang, Rong; Yuan, Yun-Fei; Xu, Rui-Hua; Li, Yu-Hong

Clinical outcomes and biomarker exploration of first-line PD-1 inhibitors plus chemotherapy in patients with low PD-L1-expressing of gastric or gastroesophageal junction adenocarcinoma

一线PD-1抑制剂联合化疗治疗PD-L1低表达胃癌或胃食管交界处腺癌患者的临床疗效及生物标志物探索

Sun, Yu-Ting; Lu, Shi-Xun; Lai, Ming-Yu; Yang, Xia; Guan, Wen-Long; Yang, Li-Qiong; Li, Yu-Hong; Wang, Feng-Hua; Yang, Da-Jun; Qiu, Miao-Zhen

CD20(high)CD138(low) tumor-infiltrating lymphocytes predominantly related to cytokine‒cytokine receptor interactions are associated with favorable outcomes in neuroblastoma patients

CD20(高)CD138(低)肿瘤浸润淋巴细胞主要与细胞因子-细胞因子受体相互作用相关,与神经母细胞瘤患者的良好预后相关。

Qin, Liang-Jun; Xu, Hui; Li, Li-Ping; Li, Shu-Hua; Xu, Shuo-Yu; Chen, Kai; Yang, Tianyou; Wang, Feng-Hua; Zuo, Liandong; Zeng, Liang; Wang, Hai-Yun